Journal of Oncology Practice · 2010 · 143 citations · 0 references
MedicineEndocrinologyOncologyBreast OncologyEndocrine OncologyEndocrine PharmacotherapyAdjuvant ChemotherapyAdjuvant PharmacotherapyAdjuvant TherapyBreast Cancer PharmacotherapyHormonal Cancer TherapyHormonal TherapyAdjuvant Hormonal TherapyAdjuvant UseAromatase InhibitionAromatase InhibitorsBreast Cancer Endocrine TherapyHormone Receptor - Positive Breast CancerHormone Receptor-positive Breast Cancer TherapyHormone Receptor-positive Disease
ASCO's technology assessment of the use of aromatase inhibitors in the adjuvant setting was last updated in 2004. ASCO's Update Committee on Aromatase Inhibitors reconvened in May 2009 to update this guideline.